Borderline personality disorder: Hypothalamus pituitary adrenal axis and findings from neuroimaging studies

Psychoneuroendocrinology

Volumn 35, Issue 1, 2010, Pages 154-170

  Wingenfeld, Katja ^a   Spitzer, Carsten ^a   Rullkötter, Nina ^b   Löwe, Bernd ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

Amygdala; Borderline personality disorder; Hippocampus; HPA axis; Neuroimaging; Stress

Indexed keywords

BORDERLINE STATE; BRAIN DAMAGE; DISEASE SEVERITY; EARLY LIFE STRESS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MENTAL DISEASE; NEUROIMAGING; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; STRESS;

BORDERLINE PERSONALITY DISORDER; BRAIN; COGNITION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNETIC RESONANCE IMAGING; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; STRESS, PSYCHOLOGICAL;

EID: 71849093249     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.09.014     Document Type: Review

References (163)

1. Baxter L., Edell W., Gerner R., Fairbanks L., and Gwirtsman H. Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder. J. Clin. Psychiatry 45 4 (1984) 150-153
2. Beblo T., Driessen M., Mertens M., Wingenfeld K., Piefke M., Rullkoetter N., et al. Functional MRI correlates of the recall of unresolved life events in borderline personality disorder. Psychol. Med. 36 6 (2006) 845-856
3. Beeber A.R., Kline M.D., Pies R.W., and Manring Jr. J.M. Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder. J. Nerv. Ment. Dis. 172 5 (1984) 301-303
4. Brambilla P., Soloff P.H., Sala M., Nicoletti M.A., Keshavan M.S., and Soares J.C. Anatomical MRI study of borderline personality disorder patients. Psychiatry Res. 131 2 (2004) 125-133
5. Bremner J.D. Does stress damage the brain?. Biol. Psychiatry 45 7 (1999) 797-805
6. Bremner J.D. Neuroimaging studies in post-traumatic stress disorder. Curr. Psychiatry Rep. 4 4 (2002) 254-263
7. Bremner J.D., Randall P., Scott T.M., Bronen R.A., Seibyl J.P., Southwick S.M., et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am. J. Psychiatry 152 7 (1995) 973-981
8. Bremner J.D., Vermetten E., Afzal N., and Vythilingam M. Deficits in verbal declarative memory function in women with childhood sexual abuse-related posttraumatic stress disorder. J. Nerv. Ment. Dis. 192 10 (2004) 643-649
9. Bremner J.D., Vermetten E., Vythilingam M., Afzal N., Schmahl C., Elzinga B., et al. Neural correlates of the classic color and emotional stroop in women with abuse-related posttraumatic stress disorder. Biol. Psychiatry 55 6 (2004) 612-620
10. Bremner J.D., Vythilingam M., Vermetten E., Southwick S.M., McGlashan T., Nazeer A., et al. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am. J. Psychiatry 160 5 (2003) 924-932
11. Buchheim A., Erk S., George C., Kachele H., Kircher T., Martius P., et al. Neural correlates of attachment trauma in borderline personality disorder: a functional magnetic resonance imaging study. Psychiatry Res. 163 3 (2008) 223-235
12. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 1-3 (2003) 235-272
13. Carroll B.J. The dexamethasone suppression test for melancholia. Br. J. Psychiatry 140 (1982) 292-304
14. Carroll B.J. Dexamethasone suppression test for depression. Adv. Biochem. Psychopharmacol. 39 (1984) 179-188
15. Carroll B.J., Greden J.F., Feinberg M., Lohr N., James N.M., Steiner M., et al. Neuroendocrine evaluation of depression in borderline patients. Psychiatr. Clin. North Am. 4 1 (1981) 89-99
16. Chanen A.M., Velakoulis D., Carison K., Gaunson K., Wood S.J., Yuen H.P., et al. Orbitofrontal, amygdala and hippocampal volumes in teenagers with first-presentation borderline personality disorder. Psychiatry Res. 163 2 (2008) 116-125
17. Daffner K.R., and Searl M.M. The dysexecutive syndromes. Handb. Clin. Neurol. 88 (2008) 249-267 (Chapter 12)
18. De La Fuente J.M., Goldman S., Stanus E., Vizuete C., Morlan I., Bobes J., et al. Brain glucose metabolism in borderline personality disorder. J. Psychiatr. Res. 31 5 (1997) 531-541
19. De la Fuente J.M., and Mendlewicz J. TRH stimulation and dexamethasone suppression in borderline personality disorder. Biol. Psychiatry 40 5 (1996) 412-418
20. Dinn W.M., Harris C.L., Aycicegi A., Greene P.B., Kirkley S.M., and Reilly C. Neurocognitive function in borderline personality disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 2 (2004) 329-341
21. Domes G., Winter B., Schnell K., Vohs K., Fast K., and Herpertz S.C. The influence of emotions on inhibitory functioning in borderline personality disorder. Psychol. Med. 36 8 (2006) 1163-1172
22. Donegan N.H., Sanislow C.A., Blumberg H.P., Fulbright R.K., Lacadie C., Skudlarski P., et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol. Psychiatry 54 11 (2003) 1284-1293
23. Driessen M., Beblo T., Mertens M., Piefke M., Rullkoetter N., Silva-Saavedra A., et al. Posttraumatic stress disorder and fMRI activation patterns of traumatic memory in patients with borderline personality disorder. Biol. Psychiatry 55 6 (2004) 603-611
24. Driessen M., Beblo T., Reddemann L., Rau H., Lange W., Silva A., et al. Ist die Borderline-Persönlichkeitsstörung eine komplexe posttraumatischen Belastungsstörung?. Nervenarzt 73 (2002) 820-829
25. Driessen M., Herrmann J., Stahl K., Zwaan M., Meier S., Hill A., et al. Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Arch. Gen. Psychiatry 57 12 (2000) 1115-1122
26. Driessen M., Wingenfeld K., Rullkoetter N., Mensebach C., Woermann F.G., Mertens M., et al. One-year functional magnetic resonance imaging follow-up study of neural activation during the recall of unresolved negative life events in borderline personality disorder. Psychol. Med. 39 3 (2009) 507-516
27. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54 7 (1997) 597-606
28. Ebner-Priemer U.W., Badeck S., Beckmann C., Wagner A., Feige B., Weiss I., et al. Affective dysregulation and dissociative experience in female patients with borderline personality disorder: a startle response study. J. Psychiatr. Res. 39 1 (2005) 85-92
29. Ebner-Priemer U.W., Mauchnik J., Kleindienst N., Schmahl C., Peper M., Rosenthal M.Z., et al. Emotional learning during dissociative states in borderline personality disorder. J. Psychiatry Neurosci. 34 3 (2009) 214-222
30. Fertuck E.A., Lenzenweger M.F., Clarkin J.F., Hoermann S., and Stanley B. Executive neurocognition, memory systems, and borderline personality disorder. Clin. Psychol. Rev. 26 3 (2006) 346-375
31. ® Axis I Disorders (SCID-I), Clinician Version (1997)
32. Gilbertson M.W., Shenton M.E., Ciszewski A., Kasai K., Lasko N.B., Orr S.P., et al. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat. Neurosci. 5 11 (2002) 1242-1247
33. Glod C.A. Long-term consequences of childhood physical and sexual abuse. Arch. Psychiatr. Nurs. 7 3 (1993) 163-173
34. Goldberg R.T., Pachas W.N., and Keith D. Relationship between traumatic events in childhood and chronic pain. Disabil. Rehabil. 21 1 (1999) 23-30
35. Golier J.A., Yehuda R., Bierer L.M., Mitropoulou V., New A.S., Schmeidler J., et al. The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. Am. J. Psychiatry 160 11 (2003) 2018-2024
36. Golier J.A., Yehuda R., Lupien S.J., Harvey P.D., Grossman R., and Elkin A. Memory performance in Holocaust survivors with posttraumatic stress disorder. Am. J. Psychiatry 159 10 (2002) 1682-1688
37. Goodwin R.D., and Stein M.B. Association between childhood trauma and physical disorders among adults in the United States. Psychol. Med. 34 3 (2004) 509-520
38. Goodyer I.M., Bacon A., Ban M., Croudace T., and Herbert J. Serotonin transporter genotype, morning cortisol and subsequent depression in adolescents. Br. J. Psychiatry 195 1 (2009) 39-45
39. Grossman R., Yehuda R., New A., Schmeidler J., Silverman J., Mitropoulou V., et al. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression. Am. J. Psychiatry 160 7 (2003) 1291-1298
40. Grossman R., Yehuda R., and Siever L. The dexamethasone suppression test and glucocorticoid receptors in borderline personality disorder. Ann. N. Y. Acad. Sci. 821 (1997) 459-464
41. Hazlett E.A., New A.S., Newmark R., Haznedar M.M., Lo J.N., Speiser L.J., et al. Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol. Psychiatry 58 8 (2005) 614-623
42. Heim C., Mletzko T., Purselle D., Musselman D.L., and Nemeroff C.B. The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol. Psychiatry 63 4 (2008) 398-405
43. Heim C., and Nemeroff C.B. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders. Biol. Psychiatry 46 11 (1999) 1509-1522
44. Heim C., and Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 49 12 (2001) 1023-1039
45. Heim C., Newport D.J., Heit S., Graham Y.P., Wilcox M., Bonsall R., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284 5 (2000) 592-597
46. Heim C., Newport D.J., Mletzko T., Miller A.H., and Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33 6 (2008) 693-710
47. Heim C., Wagner D., Maloney E., Papanicolaou D.A., Solomon L., Jones J.F., et al. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch. Gen. Psychiatry 63 11 (2006) 1258-1266
48. Herbert J., Goodyer I.M., Grossman A.B., Hastings M.H., de Kloet E.R., Lightman S.L., et al. Do corticosteroids damage the brain?. J. Neuroendocrinol. 18 6 (2006) 393-411
49. Herman J.L., Perry J.C., and van der Kolk B.A. Childhood trauma in borderline personality disorder. Am. J. Psychiatry 146 4 (1989) 490-495
50. Herpertz S., Gretzer A., Steinmeyer E.M., Muehlbauer V., Schuerkens A., and Sass H. Affective instability and impulsivity in personality disorder. Results of an experimental study. J. Affect. Disord. 44 1 (1997) 31-37
51. Herpertz S.C., Dietrich T.M., Wenning B., Krings T., Erberich S.G., Willmes K., et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol. Psychiatry 50 4 (2001) 292-298
52. Herpertz S.C., Kunert H.J., Schwenger U.B., and Sass H. Affective responsiveness in borderline personality disorder: a psychophysiological approach. Am. J. Psychiatry 156 10 (1999) 1550-1556
53. Herpertz S.C., Schwenger U.B., Kunert H.J., Lukas G., Gretzer U., Nutzmann J., et al. Emotional responses in patients with borderline as compared with avoidant personality disorder. J. Personal. Disord. 14 4 (2000) 339-351
54. Herpertz S.C., Werth U., Lukas G., Qunaibi M., Schuerkens A., Kunert H.J., et al. Emotion in criminal offenders with psychopathy and borderline personality disorder. Arch. Gen. Psychiatry 58 8 (2001) 737-745
55. Hidalgo R.B., and Davidson J.R. Posttraumatic stress disorder: epidemiology and health-related considerations. J. Clin. Psychiatry 61 Suppl. 7 (2000) 5-13
56. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 62 1-2 (2001) 77-91
57. Irle E., Lange C., and Sachsse U. Reduced size and abnormal asymmetry of parietal cortex in women with borderline personality disorder. Biol. Psychiatry 57 2 (2005) 173-182
58. Ising M., Kunzel H.E., Binder E.B., Nickel T., Modell S., and Holsboer F. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 6 (2005) 1085-1093
59. Jacob G.A., Guenzler C., Zimmermann S., Scheel C.N., Rusch N., Leonhart R., et al. Time course of anger and other emotions in women with borderline personality disorder: a preliminary study. J. Behav. Ther. Exp. Psychiatry 39 3 (2008) 391-402
60. Jelinek L., Jacobsen D., Kellner M., Larbig F., Biesold K.H., Barre K., et al. Verbal and nonverbal memory functioning in posttraumatic stress disorder (PTSD). J. Clin. Exp. Neuropsychol. 28 6 (2006) 940-948
61. Johnson J.G., Cohen P., Brown J., Smailes E.M., and Bernstein D.P. Childhood maltreatment increases risk for personality disorders during early adulthood. Arch. Gen. Psychiatry 56 7 (1999) 600-606
62. Juengling F.D., Schmahl C., Hesslinger B., Ebert D., Bremner J.D., Gostomzyk J., et al. Positron emission tomography in female patients with borderline personality disorder. J. Psychiatr. Res. 37 2 (2003) 109-115
63. Karl A., Schaefer M., Malta L.S., Dorfel D., Rohleder N., and Werner A. A meta-analysis of structural brain abnormalities in PTSD. Neurosci. Biobehav. Rev. 30 7 (2006) 1004-1031
64. Kendler K.S., Bulik C.M., Silberg J., Hettema J.M., Myers J., and Prescott C.A. Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and cotwin control analysis. Arch. Gen. Psychiatry 57 10 (2000) 953-959
65. Kendler K.S., Thornton L.M., and Gardner C.O. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am. J. Psychiatry 157 8 (2000) 1243-1251
66. Kirschbaum C., Pirke K.M., and Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 1-2 (1993) 76-81
67. Koch W., Schaaff N., Popperl G., Mulert C., Juckel G., Reicherzer M., et al. [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. J. Psychiatry Neurosci. 32 4 (2007) 234-240
68. Koenigsberg H.W., Harvey P.D., Mitropoulou V., Schmeidler J., New A.S., Goodman M., et al. Characterizing affective instability in borderline personality disorder. Am. J. Psychiatry 159 5 (2002) 784-788
69. Koenigsberg H.W., Siever L.J., Lee H., Pizzarello S., New A.S., Goodman M., et al. Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res. 172 3 (2009) 192-199
70. Kontaxakis V., Markianos M., Vaslamatzis G., Markidis M., Kanellos P., and Stefanis C. Multiple neuroendocrinological responses in borderline personality disorder patients. Acta Psychiatr. Scand. 76 5 (1987) 593-597
71. Korzekwa M., Steiner M., Links P., and Eppel A. The dexamethasone suppression test in borderlines: is it useful?. Can. J. Psychiatry 36 1 (1991) 26-28
72. Lahmeyer H.W., Reynolds III C.F., Kupfer D.J., and King R. Biologic markers in borderline personality disorder: a review. J. Clin. Psychiatry 50 6 (1989) 217-225
73. Lahmeyer H.W., Val E., Gaviria F.M., Prasad R.B., Pandey G.N., Rodgers P., et al. EEG sleep, lithium transport, dexamethasone suppression, and monoamine oxidase activity in borderline personality disorder. Psychiatry Res. 25 1 (1988) 19-30
74. Lange C., Kracht L., Herholz K., Sachsse U., and Irle E. Reduced glucose metabolism in temporo-parietal cortices of women with borderline personality disorder. Psychiatry Res. 139 2 (2005) 115-126
75. Lange W., Wulff H., Berea C., Beblo T., Saavedra A.S., Mensebach C., et al. Dexamethasone suppression test in borderline personality disorder-effects of posttraumatic stress disorder. Psychoneuroendocrinology 30 9 (2005) 919-923
76. Laplante P., Diorio J., and Meaney M.J. Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor. Brain Res. Dev. Brain Res. 139 2 (2002) 199-203
77. Lee A.L., Ogle W.O., and Sapolsky R.M. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord. 4 2 (2002) 117-128
78. Leyton M., Okazawa H., Diksic M., Paris J., Rosa P., Mzengeza S., et al. Brain regional alpha-[11C]methyl-l-tryptophan trapping in impulsive subjects with borderline personality disorder. Am. J. Psychiatry 158 5 (2001) 775-782
79. Lieb K., Rexhausen J.E., Kahl K.G., Schweiger U., Philipsen A., Hellhammer D.H., et al. Increased diurnal salivary cortisol in women with borderline personality disorder. J. Psychiatr. Res. 38 6 (2004) 559-565
80. Lieb K., Zanarini M.C., Schmahl C., Linehan M.M., and Bohus M. Borderline personality disorder. Lancet 364 9432 (2004) 453-461
81. Liu D., Diorio J., Tannenbaum B., Caldji C., Francis D., Freedman A., et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277 5332 (1997) 1659-1662
82. Lucas P.B., Gardner D.L., Cowdry R.W., and Pickar D. Cerebral structure in borderline personality disorder. Psychiatry Res. 27 2 (1989) 111-115
83. Lyoo I.K., Han M.H., and Cho D.Y. A brain MRI study in subjects with borderline personality disorder. J. Affect. Disord. 50 2-3 (1998) 235-243
84. McCauley J., Kern D.E., Kolodner K., Dill L., Schroeder A.F., DeChant H.K., et al. Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA 277 17 (1997) 1362-1368
85. McGlashan T.H., Grilo C.M., Skodol A.E., Gunderson J.G., Shea M.T., Morey L.C., et al. The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr. Scand. 102 4 (2000) 256-264
86. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonte B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 12 3 (2009) 342-348
87. McLean L.M., and Gallop R. Implications of childhood sexual abuse for adult borderline personality disorder and complex posttraumatic stress disorder. Am. J. Psychiatry 160 2 (2003) 369-371
88. Mensebach C., Beblo T., Driessen M., Wingenfeld K., Mertens M., Rullkoetter N., et al. Neural correlates of episodic and semantic memory retrieval in borderline personality disorder: an fMRI study. Psychiatry Res. 171 2 (2009) 94-105
89. Minzenberg M.J., Fan J., New A.S., Tang C.Y., and Siever L.J. Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res. 155 3 (2007) 231-243
90. Minzenberg M.J., Fan J., New A.S., Tang C.Y., and Siever L.J. Frontolimbic structural changes in borderline personality disorder. J. Psychiatr. Res. 42 9 (2008) 727-733
91. Musselmann D.L., DeBattista C., Nathan K.I., Kilts C.D., Schatzberg A.F., and Nemeroff C.B. Biology of mood disorders. In: Schatzberg A.F., and Nemeroff C.B. (Eds). Textbook of Psychopharmacology. second ed. (1998), American Psychiatry Press
92. New A.S., Buchsbaum M.S., Hazlett E.A., Goodman M., Koenigsberg H.W., Lo J., et al. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl.) 176 3-4 (2004) 451-458
93. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Mitelman S.A., Newmark R., et al. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 32 7 (2007) 1629-1640
94. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Reynolds D., Mitropoulou V., et al. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch. Gen. Psychiatry 59 7 (2002) 621-629
95. O'Leary K.M. Borderline personality disorder. Neuropsychological testing results. Psychiatr. Clin. North Am. 23 1 (2000) 41-60 vi
96. Ogata S.N., Silk K.R., Goodrich S., Lohr N.E., Westen D., and Hill E.M. Childhood sexual and physical abuse in adult patients with borderline personality disorder. Am. J. Psychiatry 147 8 (1990) 1008-1013
97. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43 4 (1991) 425-473
98. Pariante C.M., and Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49 5 (2001) 391-404
99. Pariante C.M., Papadopoulos A.S., Poon L., Checkley S.A., English J., Kerwin R.W., et al. A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis. Biol. Psychiatry 51 11 (2002) 922-930
100. Plotsky P.M., Owens M.J., and Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 21 2 (1998) 293-307
101. Renneberg B., Heyn K., Gebhard R., and Bachmann S. Facial expression of emotions in borderline personality disorder and depression. J. Behav. Ther. Exp. Psychiatry 36 3 (2005) 183-196
102. Rinne T., de Kloet E.R., Wouters L., Goekoop J.G., DeRijk R.H., and van den Brink W. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol. Psychiatry 52 11 (2002) 1102-1112
103. Rinne T., van den Brink W., Wouters L., and van Dyck R. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am. J. Psychiatry 159 12 (2002) 2048-2054
104. Rinne T., Westenberg H.G., den Boer J.A., and van den Brink W. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biol. Psychiatry 47 6 (2000) 548-556
105. Rusch N., van Elst L.T., Ludaescher P., Wilke M., Huppertz H.J., Thiel T., et al. A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage 20 1 (2003) 385-392
106. Sapolsky R.M. Depression, antidepressants, and the shrinking hippocampus. Proc. Natl. Acad. Sci. U.S.A. 98 22 (2001) 12320-12322
107. Sapolsky R.M. Chickens, eggs and hippocampal atrophy. Nat. Neurosci. 5 11 (2002) 1111-1113
108. Saß, H., Wittchen, H.U., Zaudig, M., Houben, I., 2003. Diagnostisches und Statistisches Manual Psychischer Störungen - Text revision - (DSM-IV-TR). Göttingen, Bern, Toronto, Seattle.
109. Savitz J., Lucki I., and Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Prog. Neurobiol. 88 1 (2009) 17-31
110. Schlosser N., Wolf O.T., Carvalho Fernando S., Riedesel K., Otte C., Muhtz C., et al. Effects of acute cortisol administration on autobiographical memory in patients with major depression and healthy controls. Psychoneuroendocrinology (2009) 10.1016/j.psyneuen.2009.06.015
111. Schmahl C., Berne K., Krause A., Kleindienst N., Valerius G., Vermetten E., et al. Hippocampus and amygdala volumes in patients with borderline personality disorder with or without posttraumatic stress disorder. J. Psychiatry Neurosci. 34 4 (2009) 289-295
112. Schmahl C., and Bremner J.D. Neuroimaging in borderline personality disorder. J. Psychiatr. Res. 40 5 (2006) 419-427
113. Schmahl C.G., Elzinga B.M., Vermetten E., Sanislow C., McGlashan T.H., and Bremner J.D. Neural correlates of memories of abandonment in women with and without borderline personality disorder. Biol. Psychiatry 54 2 (2003) 142-151
114. Schmahl C.G., McGlashan T.H., and Bremner J.D. Neurobiological correlates of borderline personality disorder. Psychopharmacol. Bull. 36 2 (2002) 69-87
115. Schmahl C.G., Vermetten E., Elzinga B.M., and Bremner J.D. A positron emission tomography study of memories of childhood abuse in borderline personality disorder. Biol. Psychiatry 55 7 (2004) 759-765
116. Schmahl C.G., Vermetten E., Elzinga B.M., and Douglas Bremner J. Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Res. 122 3 (2003) 193-198
117. Schnell K., Dietrich T., Schnitker R., Daumann J., and Herpertz S.C. Processing of autobiographical memory retrieval cues in borderline personality disorder. J. Affect. Disord. 97 1-3 (2007) 253-259
118. Schnell K., and Herpertz S.C. Effects of dialectic-behavioral-therapy on the neural correlates of affective hyperarousal in borderline personality disorder. J. Psychiatr. Res. 41 10 (2007) 837-847
119. Sheline Y.I., Sanghavi M., Mintun M.A., and Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 19 12 (1999) 5034-5043
120. Shin L.M., Whalen P.J., Pitman R.K., Bush G., Macklin M.L., Lasko N.B., et al. An fMRI study of anterior cingulate function in posttraumatic stress disorder. Biol. Psychiatry 50 12 (2001) 932-942
121. Silbersweig D., Clarkin J.F., Goldstein M., Kernberg O.F., Tuescher O., Levy K.N., et al. Failure of frontolimbic inhibitory function in the context of negative emotion in borderline personality disorder. Am. J. Psychiatry 164 12 (2007) 1832-1841
122. Simeon D., Knutelska M., Smith L., Baker B.R., and Hollander E. A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation. Psychiatry Res. 149 1-3 (2007) 177-184
123. Skodol A.E., Gunderson J.G., Pfohl B., Widiger T.A., Livesley W.J., and Siever L.J. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol. Psychiatry 51 12 (2002) 936-950
124. Smythe J.W., Rowe W.B., and Meaney M.J. Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: relationship to the handling effect on glucocorticoid receptor expression. Brain Res. Dev. Brain Res. 80 1-2 (1994) 183-189
125. Snyder S., Pitts Jr. W.M., and Gustin Q. CT scans of patients with borderline personality disorder. Am. J. Psychiatry 140 2 (1983) 272
126. Soloff P., Nutche J., Goradia D., and Diwadkar V. Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study. Psychiatry Res. 164 3 (2008) 223-236
127. Soloff P.H., George A., and Nathan R.S. The dexamethasone suppression test in patients with borderline personality disorders. Am. J. Psychiatry 139 12 (1982) 1621-1623
128. Soloff P.H., Kelly T.M., Strotmeyer S.J., Malone K.M., and Mann J.J. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res. 119 1-2 (2003) 11-24
129. Soloff P.H., Lynch K.G., Kelly T.M., Malone K.M., and Mann J.J. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am. J. Psychiatry 157 4 (2000) 601-608
130. Soloff P.H., Meltzer C.C., Becker C., Greer P.J., and Constantine D. Gender differences in a fenfluramine-activated FDG PET study of borderline personality disorder. Psychiatry Res. 138 3 (2005) 183-195
131. Soloff P.H., Meltzer C.C., Becker C., Greer P.J., Kelly T.M., and Constantine D. Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Res. 123 3 (2003) 153-163
132. Soloff P.H., Meltzer C.C., Greer P.J., Constantine D., and Kelly T.M. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol. Psychiatry 47 6 (2000) 540-547
133. Soloff P.H., Price J.C., Meltzer C.C., Fabio A., Frank G.K., and Kaye W.H. 5HT2A receptor binding is increased in borderline personality disorder. Biol. Psychiatry 62 6 (2007) 580-587
134. Southwick S.M., Axelrod S.R., Wang S., Yehuda R., Morgan III C.A., Charney D., et al. Twenty-four-hour urine cortisol in combat veterans with PTSD and comorbid borderline personality disorder. J. Nerv. Ment. Dis. 191 4 (2003) 261-262
135. Sternbach H.A., Fleming J., Extein I., Pottash A.L., and Gold M.S. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients. Psychoneuroendocrinology 8 4 (1983) 459-462
136. Stiglmayr C.E., Ebner-Priemer U.W., Bretz J., Behm R., Mohse M., Lammers C.H., et al. Dissociative symptoms are positively related to stress in borderline personality disorder. Acta Psychiatr. Scand. 117 2 (2008) 139-147
137. Stone M.H. Long-term outcome in personality disorders. Br. J. Psychiatry 162 (1993) 299-313
138. Szyf M., McGowan P., and Meaney M.J. The social environment and the epigenome. Environ. Mol. Mutagen 49 1 (2008) 46-60
139. Tebartz van Elst L., Hesslinger B., Thiel T., Geiger E., Haegele K., Lemieux L., et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol. Psychiatry 54 2 (2003) 163-171
140. Tebartz van Elst L., Ludaescher P., Thiel T., Buchert M., Hesslinger B., Bohus M., et al. Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder. Neurosci. Lett. 417 1 (2007) 36-41
141. Van Praag H.M., De Kloet R., and van Os J. Stress the Brain and Depression (2004), Cambridge University Press
142. Videbech P., and Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 161 11 (2004) 1957-1966
143. Villarreal G., Hamilton D.A., Petropoulos H., Driscoll I., Rowland L.M., Griego J.A., et al. Reduced hippocampal volume and total white matter volume in posttraumatic stress disorder. Biol. Psychiatry 52 2 (2002) 119-125
144. Vythilingam M., Heim C., Newport J., Miller A.H., Anderson E., Bronen R., et al. Childhood trauma associated with smaller hippocampal volume in women with major depression. Am. J. Psychiatry 159 12 (2002) 2072-2080
145. Walter M., Bureau J.F., Holmes B.M., Bertha E.A., Hollander M., Wheelis J., et al. Cortisol response to interpersonal stress in young adults with borderline personality disorder: a pilot study. Eur. Psychiatry 23 3 (2008) 201-204
146. Watson S., Gallagher P., Smith M.S., Ferrier I.N., and Young A.H. The dex/CRH test-Is it better than the DST?. Psychoneuroendocrinology 31 7 (2006) 889-894
147. Whittle S., Chanen A.M., Fornito A., McGorry P.D., Pantelis C., and Yucel M. Anterior cingulate volume in adolescents with first-presentation borderline personality disorder. Psychiatry Res. 172 2 (2009) 155-160
148. Williams J.M., Mathews A., and MacLeod C. The emotional Stroop task and psychopathology. Psychol. Bull. 120 1 (1996) 3-24
149. Wingenfeld K., Driessen M., Adam B., and Hill A. Overnight urinary cortisol release in women with borderline personality disorder depends on comorbid PTSD and depressive psychopathology. Eur. Psychiatry 22 5 (2007) 309-312
150. Wingenfeld K., Hill A., Adam B., and Driessen M. Dexamethasone suppression test in borderline personality disorder: impact of PTSD symptoms. Psychiatry Clin. Neurosci. 61 6 (2007) 681-683
151. Wingenfeld K., Lange W., Wulff H., Berea C., Beblo T., Saavedra A.S., et al. Stability of the dexamethasone suppression test in borderline personality disorder with and without comorbid PTSD: a one-year follow-up study. J. Clin. Psychol. 63 9 (2007) 843-850
152. Wingenfeld K., Mensebach C., Rullkoetter N., Schlosser N., Schaffrath C., Woermann F.G., et al. Attentional bias to personally relevant words in borderline personality disorder is strongly related to comorbid posttraumatic stress disorder. J. Pers. Disord. 23 2 (2009) 141-155
153. Wingenfeld K., Rullkoetter N., Mensebach C., Beblo T., Mertens M., Kreisel S., et al. Neural correlates of the individual emotional Stroop in borderline personality disorder. Psychoneuroendocrinology 34 4 (2009) 571-586
154. Wolf O.T. HPA axis and memory. Best Pract. Res. Clin. Endocrinol. Metab. 17 2 (2003) 287-299
155. Yehuda R. Biology of posttraumatic stress disorder. J. Clin. Psychiatry 61 Suppl. 7 (2000) 14-21
156. Yehuda R., Southwick S.M., Krystal J.H., Bremner D., Charney D.S., and Mason J.W. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am. J. Psychiatry 150 1 (1993) 83-86
157. Yen S., Shea M.T., Sanislow C.A., Grilo C.M., Skodol A.E., Gunderson J.G., et al. Borderline personality disorder criteria associated with prospectively observed suicidal behavior. Am. J. Psychiatry 161 7 (2004) 1296-1298
158. Zanarini M.C., Frankenburg F.R., Dubo E.D., Sickel A.E., Trikha A., Levin A., et al. Axis I comorbidity of borderline personality disorder. Am. J. Psychiatry 155 12 (1998) 1733-1739
159. Zanarini M.C., Frankenburg F.R., Hennen J., Reich D.B., and Silk K.R. Prediction of the 10-year course of borderline personality disorder. Am. J. Psychiatry 163 5 (2006) 827-832
160. Zanarini M.C., Williams A.A., Lewis R.E., Reich R.B., Vera S.C., Marino M.F., et al. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am. J. Psychiatry 154 8 (1997) 1101-1106
161. Zetzsche T., Frodl T., Preuss U.W., Schmitt G., Seifert D., Leinsinger G., et al. Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol. Psychiatry 60 3 (2006) 302-310
162. Zetzsche T., Preuss U.W., Bondy B., Frodl T., Zill P., Schmitt G., et al. 5-HT1A receptor gene C-1019 G polymorphism and amygdala volume in borderline personality disorder. Genes Brain Behav. 7 3 (2008) 306-313
163. Zetzsche T., Preuss U.W., Frodl T., Schmitt G., Seifert D., Munchhausen E., et al. Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder. Psychiatry Res. 154 2 (2007) 157-170